Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa
- PMID: 23774442
- PMCID: PMC3754285
- DOI: 10.1128/AAC.00493-13
Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa
Abstract
The dynamics of occurrence and the genetic basis of ciprofloxacin resistance were studied in a long-term evolution experiment (940 generations) in wild-type, reference strain (PAO1) and hypermutable (PAOΔmutS and PAOMY-Mgm) P. aeruginosa populations continuously exposed to sub-MICs (1/4) of ciprofloxacin. A rapid occurrence of ciprofloxacin-resistant mutants (MIC of ≥12 μg/ml, representing 100 times the MIC of the original population) were observed in all ciprofloxacin-exposed lineages of PAOΔmutS and PAOMY-Mgm populations after 100 and 170 generations, respectively, and in one of the PAO1 lineages after 240 generations. The genetic basis of resistance was mutations in gyrA (C248T and G259T) and gyrB (C1397A). Cross-resistance to beta-lactam antibiotics was observed in the bacterial populations that evolved during exposure to sublethal concentrations of ciprofloxacin. Our study shows that mutants with high-level ciprofloxacin resistance are selected in P. aeruginosa bacterial populations exposed to sub-MICs of ciprofloxacin. This can have implications for the long-term persistence of resistant bacteria and spread of antibiotic resistance by exposure of commensal bacterial flora to low antibiotic concentrations.
Figures
Similar articles
-
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.J Antimicrob Chemother. 2005 Aug;56(2):353-9. doi: 10.1093/jac/dki204. Epub 2005 Jun 20. J Antimicrob Chemother. 2005. PMID: 15967767
-
Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.Antimicrob Agents Chemother. 2016 Jun 20;60(7):4229-36. doi: 10.1128/AAC.00434-16. Print 2016 Jul. Antimicrob Agents Chemother. 2016. PMID: 27139485 Free PMC article.
-
Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2006 Mar;50(3):975-83. doi: 10.1128/AAC.50.3.975-983.2006. Antimicrob Agents Chemother. 2006. PMID: 16495260 Free PMC article.
-
Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Antimicrob Agents Chemother. 2016 Jan 4;60(3):1767-78. doi: 10.1128/AAC.02676-15. Antimicrob Agents Chemother. 2016. PMID: 26729493 Free PMC article.
-
Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem.J Med Microbiol. 2019 Jan;68(1):1-10. doi: 10.1099/jmm.0.000873. J Med Microbiol. 2019. PMID: 30605076 Review.
Cited by
-
Comparative molecular profiling of multidrug-resistant Pseudomonas aeruginosa identifies novel mutations in regional clinical isolates from South India.JAC Antimicrob Resist. 2024 Jan 16;6(1):dlae001. doi: 10.1093/jacamr/dlae001. eCollection 2024 Feb. JAC Antimicrob Resist. 2024. PMID: 38230352 Free PMC article.
-
Rolling the evolutionary dice: Neisseria commensals as proxies for elucidating the underpinnings of antibiotic resistance mechanisms and evolution in human pathogens.Microbiol Spectr. 2024 Feb 6;12(2):e0350723. doi: 10.1128/spectrum.03507-23. Epub 2024 Jan 5. Microbiol Spectr. 2024. PMID: 38179941 Free PMC article.
-
The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of Pseudomonas aeruginosa populations in cystic fibrosis lung infection.mBio. 2024 Feb 14;15(2):e0310923. doi: 10.1128/mbio.03109-23. Epub 2024 Jan 3. mBio. 2024. PMID: 38171021 Free PMC article.
-
Specific phenotypic, genomic, and fitness evolutionary trajectories toward streptomycin resistance induced by pesticide co-stressors in Escherichia coli.ISME Commun. 2021 Aug 18;1(1):39. doi: 10.1038/s43705-021-00041-z. ISME Commun. 2021. PMID: 37938677 Free PMC article.
-
Eradication of Bacterial Persister Cells By Leveraging Their Low Metabolic Activity Using Adenosine Triphosphate Coated Gold Nanoclusters.Nano Today. 2023 Aug;51:101895. doi: 10.1016/j.nantod.2023.101895. Epub 2023 Jun 12. Nano Today. 2023. PMID: 37575958
References
-
- Oliver A, Canton R, Campo P, Baquero F, Blazquez J. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251–1254 - PubMed
-
- Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797–810 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
